A detailed history of Silver Lake Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Silver Lake Advisory, LLC holds 1,637 shares of LLY stock, worth $1.26 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,637
Previous 1,653 0.97%
Holding current value
$1.26 Million
Previous $1.5 Million 3.07%
% of portfolio
0.32%
Previous 0.37%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $12,354 - $15,360
-16 Reduced 0.97%
1,637 $1.45 Million
Q2 2024

Aug 15, 2024

SELL
$724.87 - $909.04 $70,312 - $88,176
-97 Reduced 5.54%
1,653 $1.5 Million
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $50,016 - $62,723
69 Added 4.1%
1,750 $1.58 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $995,488 - $1.33 Million
1,681 New
1,681 $1.31 Million
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $701 - $937
2 Added 0.12%
1,698 $796,000
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $526,828 - $618,734
1,696 New
1,696 $582,000
Q3 2022

Oct 20, 2022

BUY
$296.48 - $337.87 $592 - $675
2 Added 0.12%
1,692 $547,000
Q2 2022

Jul 28, 2022

BUY
$278.73 - $327.27 $557 - $654
2 Added 0.12%
1,690 $548,000
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $469 - $583
2 Added 0.12%
1,688 $483,000
Q4 2021

Jan 13, 2022

BUY
$224.85 - $279.04 $449 - $558
2 Added 0.12%
1,686 $466,000
Q3 2021

Oct 28, 2021

BUY
$221.6 - $272.71 $664 - $818
3 Added 0.18%
1,684 $389,000
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $361 - $467
2 Added 0.12%
1,681 $430,000
Q1 2021

Apr 27, 2021

BUY
$164.32 - $212.72 $492 - $638
3 Added 0.18%
1,679 $314,000
Q4 2020

Feb 04, 2021

BUY
$130.46 - $172.63 $196,603 - $260,153
1,507 Added 891.72%
1,676 $283,000
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $196,211 - $259,635
-1,504 Reduced 89.9%
169 $283,000
Q3 2020

Nov 04, 2020

BUY
$146.22 - $169.13 $438 - $507
3 Added 0.18%
1,673 $248,000
Q2 2020

Jul 28, 2020

BUY
$136.42 - $164.18 $409 - $492
3 Added 0.18%
1,670 $274,000
Q1 2020

Apr 22, 2020

SELL
$119.05 - $147.35 $401,317 - $496,716
-3,371 Reduced 66.91%
1,667 $231,000
Q1 2020

Apr 21, 2020

BUY
$119.05 - $147.35 $401,674 - $497,158
3,374 Added 202.76%
5,038 $236,000
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $177,914 - $220,363
1,664 New
1,664 $219,000
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $183,246 - $213,895
-1,654 Closed
0 $0
Q1 2019

Apr 18, 2019

SELL
$111.31 - $131.02 $23.7 Million - $27.9 Million
-212,932 Reduced 99.23%
1,654 $215,000
Q1 2019

Apr 17, 2019

BUY
$111.31 - $131.02 $23.6 Million - $27.8 Million
212,083 Added 8473.15%
214,586 $215,000
Q4 2018

Feb 05, 2019

BUY
$105.9 - $118.64 $529 - $593
5 Added 0.2%
2,503 $290,000
Q3 2018

Oct 16, 2018

BUY
$85.86 - $107.31 $1,803 - $2,253
21 Added 0.85%
2,498 $268,000
Q3 2018

Oct 15, 2018

BUY
$85.86 - $107.31 $944 - $1,180
11 Added 0.45%
2,477 $212,000
Q2 2018

Jul 16, 2018

BUY
$75.7 - $86.88 $186,676 - $214,246
2,466 New
2,466 $203,000
Q1 2018

Apr 17, 2018

SELL
$74.21 - $87.6 $184,189 - $217,423
-2,482 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$81.94 - $87.89 $409 - $439
5 Added 0.2%
2,482 $210,000
Q3 2017

Oct 17, 2017

BUY
$77.07 - $85.54 $190,902 - $211,882
2,477
2,477 $212,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Silver Lake Advisory, LLC Portfolio

Follow Silver Lake Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Lake Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silver Lake Advisory, LLC with notifications on news.